All translations
Jump to navigation
Jump to search
Enter a message name below to show all available translations.
Found 2 translations.
| Name | Current message text |
|---|---|
| h English (en) | Typical reductions in [[glycated hemoglobin]] (A1C) values for second-generation sulfonylureas are 1.0–2.0%. * First-generation agents ** [[tolbutamide]] ** [[acetohexamide]] ** [[tolazamide]] ** [[chlorpropamide]] * Second-generation agents ** [[glipizide]] ** glyburide or [[glibenclamide]] ** [[glimepiride]] ** [[gliclazide]] ** [[glyclopyramide]] ** [[gliquidone]] |
| h Japanese (ja) | 第二世代スルホニル尿素薬の典型的な[[glycated hemoglobin/ja|糖化ヘモグロビン]] (A1C)値の減少は1.0-2.0％である。 * 第一世代の薬剤 ** [[tolbutamide/ja]] ** [[acetohexamide/ja]] ** [[tolazamide/ja]] ** [[chlorpropamide/ja]] * 第二世代の薬剤 ** [[glipizide/ja]] ** グリブリド、あるいは[[glibenclamidex/ja]] ** [[glimepiride/ja]] ** [[gliclazide/ja]] ** [[glyclopyramide/ja]] ** [[gliquidone/ja]] |